NASDAQ:CRON Cronos Group (CRON) Stock Price, News & Analysis $3.04 -0.04 (-1.30%) Closing price 11/20/2026 04:00 PM EasternExtended Trading$3.06 +0.02 (+0.76%) As of 11/20/2026 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Cronos Group Stock (NASDAQ:CRON) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Cronos Group alerts:Sign Up Key Stats Today's Range$3.02▼$3.1250-Day Range$3.04▼$3.7152-Week Range$2.28▼$3.91Volume1.92 million shsAverage Volume1.19 million shsMarket Capitalization$1.11 billionP/E Ratio17.88Dividend YieldN/APrice Target$2.30Consensus RatingBuy Company Overview Cronos Group is a cannabinoid company that develops, produces, and markets cannabis and cannabis-derived products. Its business includes cultivation, processing, product development, and distribution. The company sells products in categories such as dried cannabis flower, pre-rolls, vaporizers, edibles, and extracts. Its brand portfolio includes Spinach and PEACE NATURALS. Founded in 2012 and headquartered in Toronto, Cronos serves consumers in Canada and select international markets, including Israel.AI Generated. May Contain Errors. Read More Cronos Group Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks53rd Percentile Overall ScoreCRON MarketRank™: 2.6688667322 of 5 starsCronos Group scored higher than 53% of companies evaluated by MarketBeat, and ranked 353rd out of 837 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.1 / 5Analyst RatingBuy Consensus RatingCronos Group has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 strong buy rating, 3 buy ratings, 1 hold rating, and no sell ratings.Downside RiskCronos Group has a consensus price target of $2.30, representing about 24.3% downside from its current price of $3.04.Amount of Analyst CoverageCronos Group has only been the subject of 3 research reports in the past 90 days.Read more about Cronos Group's stock forecast and price target. Earnings and Valuation3.8 / 5Proj. Earnings Growth62.50% Earnings GrowthEarnings for Cronos Group are expected to grow by 62.50% in the coming year, from $0.16 to $0.26 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Cronos Group is 17.88, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.17.Price to Earnings Ratio vs. SectorThe P/E ratio of Cronos Group is 17.88, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 32.56.Price to Book Value per Share RatioCronos Group has a P/B Ratio of 0.99. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted1.23% of the float of Cronos Group has been sold short.Short Interest Ratio / Days to CoverCronos Group has a short interest ratio ("days to cover") of 4.94.Change versus previous monthShort interest in Cronos Group has recently increased by 4.87%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCronos Group does not currently pay a dividend.Dividend GrowthCronos Group does not have a long track record of dividend growth. News and Social Media2.7 / 5News Sentiment0.31 News SentimentCronos Group has a news sentiment score of 0.31. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.42 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Cronos Group this week, compared to 4 articles on an average week.Search InterestOnly 4 people have searched for CRON on MarketBeat in the last 30 days. This is a decrease of -20% compared to the previous 30 days.MarketBeat Follows5 people have added Cronos Group to their MarketBeat watchlist in the last 30 days. This is an increase of 67% compared to the previous 30 days. Company Ownership0.4 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Cronos Group insiders have not sold or bought any company stock.Percentage Held by Insiders7.80% of the stock of Cronos Group is held by insiders.Percentage Held by Institutions8.71% of the stock of Cronos Group is held by institutions.Read more about Cronos Group's insider trading history. Receive CRON Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cronos Group and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CRON Stock News Headlines3 Canadian Penny Stocks To Own In November 2026November 18, 2026 | finance.yahoo.comTop 3 Canadian Penny Stocks With Liabilities At 100% Higher Risk FundingNovember 17, 2026 | finance.yahoo.com$0. Later: $29.97.Bill Poulos is giving away his Simple Options Trading For Beginners book through a temporary link. Once that link expires, it returns to its usual price of $29.97. The content stays the same - plain-English lessons and a handful of proven techniques - only the price changes. Waiting means paying for something you could have gotten for free.November 22 at 1:00 AM | Profits Run (Ad)Top 3 Canadian Penny Stocks To Watch In November 2026November 16, 2026 | finance.yahoo.comCanadian Penny Stocks To Watch In November 2026November 14, 2026 | finance.yahoo.comTop 3 Canadian Penny Stocks To Watch In November 2026November 11, 2026 | finance.yahoo.comCronos Group (CRON) Q3 2026 Earnings Call TranscriptNovember 6, 2026 | fool.comCronos Group (TSX:CRON) Stock Looks Hard To Call Following Its 93% RunNovember 6, 2026 | finance.yahoo.comSee More Headlines CRON Stock Analysis - Frequently Asked Questions How have CRON shares performed this year? Cronos Group's stock was trading at $2.63 at the beginning of the year. Since then, CRON stock has increased by 15.6% and is now trading at $3.04. How were Cronos Group's earnings last quarter? Cronos Group Inc. (NASDAQ:CRON) issued its quarterly earnings data on Thursday, November, 5th. The company reported $0.04 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.03 by $0.01. The firm had revenue of $63.45 million for the quarter, compared to analysts' expectations of $51.15 million. Cronos Group had a net margin of 28.04% and a trailing twelve-month return on equity of 2.56%. Read the conference call transcript. Who are Cronos Group's major shareholders? Cronos Group's top institutional investors include Cibc World Market Inc. (0.35%), Silver Oak Securities Incorporated (0.19%), Goldman Sachs Group Inc. (0.18%) and HighTower Advisors LLC (0.10%). View institutional ownership trends. How do I buy shares of Cronos Group? Shares of CRON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Cronos Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cronos Group investors own include Canopy Growth (CGC), Aurora Cannabis (ACB), Tilray Brands (TLRY), NVIDIA (NVDA), Advanced Micro Devices (AMD), Micron Technology (MU) and Tesla (TSLA). Company Calendar Last Earnings11/05/2026Today11/22/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (7m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 CRON's financial health is in the Green zone, according to TradeSmith. CRON has been in this zone for over 7 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNASDAQ:CRON CIK1656472 Webwww.thecronosgroup.com Phone(416) 504-0004FaxN/AEmployees610Year Founded2013Price Target and Rating Average Price Target for Cronos Group$2.30 High Price Target$2.30 Low Price Target$2.30 Potential Upside/Downside-24.3%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage5 Analysts Profitability EPS (Trailing Twelve Months)$0.17 Trailing P/E Ratio17.88 Forward P/E Ratio11.69 P/E GrowthN/ANet Income-$9.45 million Net Margins28.04% Pretax Margin29.19% Return on Equity2.56% Return on Assets2.43% Debt Debt-to-Equity RatioN/A Current Ratio12.71 Quick Ratio11.91 Sales & Book Value Annual Sales$206.20 million Price / Sales5.40 Cash Flow$0.01 per share Price / Cash Flow242.48 Book Value$3.07 per share Price / Book0.99Miscellaneous Outstanding Shares366,471,000Free Float337,886,000Market Cap$1.11 billion OptionableOptionable Beta0.96 Social Links The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (NASDAQ:CRON) was last updated on 11/20/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredELON + YOU + DECEMBER 8THElon Musk's next big project may be the most ambitious move of his career, and all signs point to December 8th...Paradigm Press | SponsoredCFA: Bank of America Said THISOn January 24th, 2022, Bank of America told Bloomberg something that should terrify every American with a savi...Decentralized Masters | SponsoredThe warning signs most investors see too lateDr. Martin D. Weiss has publicly predicted six major American crashes since founding Weiss Ratings in 1971. ...Weiss Ratings | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredBeyond NVDA: The World’s Next #1 Company?This small-cap trades in an overlooked corner of the market, with a market cap more than 600X smaller than Nvi...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cronos Group Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cronos Group With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.